Home Cart 0 Sign in  

[ CAS No. 5382-49-0 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 5382-49-0
Chemical Structure| 5382-49-0
Structure of 5382-49-0 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 5382-49-0 ]

Related Doc. of [ 5382-49-0 ]

Alternatived Products of [ 5382-49-0 ]

Product Details of [ 5382-49-0 ]

CAS No. :5382-49-0 MDL No. :MFCD00957087
Formula : C10H11NO2 Boiling Point : -
Linear Structure Formula :- InChI Key :ARNALYPZOYPNAF-UHFFFAOYSA-N
M.W : 177.20 Pubchem ID :2779641
Synonyms :

Calculated chemistry of [ 5382-49-0 ]

Physicochemical Properties

Num. heavy atoms : 13
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.3
Num. rotatable bonds : 1
Num. H-bond acceptors : 2.0
Num. H-bond donors : 2.0
Molar Refractivity : 53.3
TPSA : 49.33 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.09 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.44
Log Po/w (XLOGP3) : 1.82
Log Po/w (WLOGP) : 1.17
Log Po/w (MLOGP) : 0.44
Log Po/w (SILICOS-IT) : 1.77
Consensus Log Po/w : 1.33

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.56

Water Solubility

Log S (ESOL) : -2.36
Solubility : 0.772 mg/ml ; 0.00436 mol/l
Class : Soluble
Log S (Ali) : -2.48
Solubility : 0.593 mg/ml ; 0.00334 mol/l
Class : Soluble
Log S (SILICOS-IT) : -2.65
Solubility : 0.397 mg/ml ; 0.00224 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.59

Safety of [ 5382-49-0 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 5382-49-0 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 5382-49-0 ]
  • Downstream synthetic route of [ 5382-49-0 ]

[ 5382-49-0 ] Synthesis Path-Upstream   1~9

  • 1
  • [ 5382-49-0 ]
  • [ 10349-57-2 ]
Reference: [1] Journal of the American Chemical Society, 2015, vol. 137, # 33, p. 10652 - 10658
[2] ChemCatChem, 2013, vol. 5, # 8, p. 2183 - 2186
  • 2
  • [ 10349-57-2 ]
  • [ 5382-49-0 ]
Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2011, vol. 21, # 2, p. 670 - 676
[2] ChemCatChem, 2013, vol. 5, # 8, p. 2183 - 2186
[3] Angewandte Chemie - International Edition, 2017, vol. 56, # 12, p. 3216 - 3220[4] Angew. Chem., 2017, vol. 129, # 12, p. 3264 - 3268,5
[5] Catalysis Science and Technology, 2017, vol. 7, # 10, p. 1981 - 1985
[6] ACS Catalysis, 2018, vol. 8, # 5, p. 4545 - 4557
[7] Chemistry of Heterocyclic Compounds (New York, NY, United States), 1988, vol. 24, p. 65 - 67[8] Khimiya Geterotsiklicheskikh Soedinenii, 1988, vol. 24, # 1, p. 77 - 79
[9] Tetrahedron Letters, 2004, vol. 45, # 16, p. 3215 - 3217
[10] Chemische Berichte, 1902, vol. 35, p. 2613
[11] Patent: US5385909, 1995, A,
[12] Patent: US2004/122001, 2004, A1,
[13] ACS Catalysis, 2018, vol. 8, # 1, p. 17 - 21
  • 3
  • [ 851202-94-3 ]
  • [ 5382-49-0 ]
YieldReaction ConditionsOperation in experiment
61% for 18 h; Heating / reflux l-Acetyl-1, 2,3, 4-tetrahydro-quinoline-6-carbonitrile (50 mmol) was refluxed in HC1 (8M) (150 mL) for 18h. The mixture was cooled and pH adjusted to approx. 3 with NaOH. The product precipitated and was removed by filtration, washed with water and dried. Yield: 61percent 1H NMR (D6-DMSO) : 1.79 (m, 2H); 2.68 (m, 2H) ; 3.23 (m, 2H); 5.45 (br, 1H) ; 6. 48 (d, 1H) ; 7.45-7. 50 (2H).
Reference: [1] Patent: WO2005/39572, 2005, A1, . Location in patent: Page/Page column 31-32
  • 4
  • [ 50741-36-1 ]
  • [ 5382-49-0 ]
Reference: [1] Tetrahedron, 2005, vol. 61, # 16, p. 4035 - 4041
  • 5
  • [ 635-46-1 ]
  • [ 5382-49-0 ]
Reference: [1] Tetrahedron, 2005, vol. 61, # 16, p. 4035 - 4041
  • 6
  • [ 22190-35-8 ]
  • [ 5382-49-0 ]
Reference: [1] Tetrahedron, 2005, vol. 61, # 16, p. 4035 - 4041
  • 7
  • [ 186581-53-3 ]
  • [ 5382-49-0 ]
  • [ 177478-49-8 ]
YieldReaction ConditionsOperation in experiment
100% at -78 - 20℃; for 6 h; Example 24a; Pyridin-3-ylmethyl 6-(2-amino-5-(thiophen-2-yl)phenylcarbamoyl)-3,4-dihydroquino-line- l(2H)-carboxylate (216); Scheme 24; Step 1 : Methyl l,2,3,4-tetrahvdroquinoline-6-carboxylate (212); [0827] A mixture of 50percent potassium hydroxide in H2O (30 mL) and diethyl ether (100 mL), stirred at 0 0C, was treated portion- wise with solid iV-nitroso-jV-methyl urea (3.Og, 29.1 mmol).The reaction mixture was stirred for 30 min then transferred into a separatory funnel, the aqueous layer was discarded and the yellow etheral phase (diazomethane solution) was cooled to -78 0C in an Erlenmeyer flask. To a solution of acid 211 (1.Og, 5.65 mmol) in THF (100 mL), stirred at0 0C, was added the etheral solution of diazomethane (kept at -78 0C) drop wise. After the addition, the reaction mixture was stirred at 0 0C for 2 h then at room temperature for 4 h, and concentrated to give title compound 212 as a reddish solid (100percent yield).[0828] 1H NMR (DMSO-d6) δ (ppm): 7.47 to 7.45 (m, 2H), 6.63 (s, IH), 6.42 (d, J= 8.4 Hz,IH), 3.71 (s, 3H), 3.24-3.21 (m, 2H), 2.67 (t, J= 6.3 Hz, 2H), 1.80-1.74 (m, 2H).
Reference: [1] Patent: WO2007/118137, 2007, A1, . Location in patent: Page/Page column 131
[2] Patent: WO2007/81335, 2007, A1, . Location in patent: Page/Page column 36-37
  • 8
  • [ 67-56-1 ]
  • [ 5382-49-0 ]
  • [ 177478-49-8 ]
YieldReaction ConditionsOperation in experiment
45 g at 0 - 20℃; for 12 h; Step 1
Methyl 1,2,3,4-tetrahydroquinoline-6-carboxylate
1,2,3,4-tetrahydroquinoline-6-carboxylic acid (50 g, 282 mmol) was dissolved in MeOH (500 mL) in a 2 L flask, to which AcCl (100 mL) was added at 0° C., followed by stirring at room temperature for 12 hours.
Upon completion of the reaction, the reaction mixture was concentrated under reduced pressure to give methyl 1,2,3,4-tetrahydroquinoline-6-carboxylate (45 g).
Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2011, vol. 21, # 2, p. 670 - 676
[2] Patent: US2016/355483, 2016, A1, . Location in patent: Paragraph 0323-0324
  • 9
  • [ 5382-49-0 ]
  • [ 157-22-2 ]
  • [ 177478-49-8 ]
Reference: [1] Patent: US2006/178398, 2006, A1, . Location in patent: Page/Page column 21-22
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 5382-49-0 ]

Carboxylic Acids

Chemical Structure| 15861-30-0

[ 15861-30-0 ]

Indoline-5-carboxylic acid

Similarity: 0.95

Chemical Structure| 4740-24-3

[ 4740-24-3 ]

4-(Butylamino)benzoic acid

Similarity: 0.91

Chemical Structure| 70639-77-9

[ 70639-77-9 ]

2-Oxo-1,2,3,4-tetrahydroquinoline-6-carboxylic acid

Similarity: 0.89

Chemical Structure| 88371-24-8

[ 88371-24-8 ]

2-Oxo-1,2,3,4-tetrahydroquinoline-7-carboxylic acid

Similarity: 0.89

Chemical Structure| 168899-63-6

[ 168899-63-6 ]

1-Methylindoline-4-carboxylic acid

Similarity: 0.89

Related Parent Nucleus of
[ 5382-49-0 ]

Tetrahydroquinolines

Chemical Structure| 177478-49-8

[ 177478-49-8 ]

Methyl 1,2,3,4-tetrahydroquinoline-6-carboxylate

Similarity: 0.92

Chemical Structure| 70639-77-9

[ 70639-77-9 ]

2-Oxo-1,2,3,4-tetrahydroquinoline-6-carboxylic acid

Similarity: 0.89

Chemical Structure| 88371-24-8

[ 88371-24-8 ]

2-Oxo-1,2,3,4-tetrahydroquinoline-7-carboxylic acid

Similarity: 0.89

Chemical Structure| 88371-29-3

[ 88371-29-3 ]

2-Oxo-1,2,3,4-tetrahydroquinoline-5-carboxylic acid

Similarity: 0.88

Chemical Structure| 1000045-93-1

[ 1000045-93-1 ]

Methyl 2-oxo-1,2,3,4-tetrahydroquinoline-7-carboxylate

Similarity: 0.82